Skip to content

Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery

Clinical Performance of Two 0.2% Chlorhexidine Mouth Rinses After Periodontal Surgery. A Blinded, Intra-individual Cross-over Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04223076
Enrollment
31
Registered
2020-01-10
Start date
2019-03-20
Completion date
2020-12-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Plaque, Periodontal Diseases, Periodontitis

Keywords

Periodontal Index

Brief summary

Chlorhexidine is the gold standard of dental plaque prevention. Recent research have demonstrated that 0.2% Chlorhexidine solutions are more effective than 0.12% and 0.06% Chlorhexidine solutions. Several 0.2% solutions are available on the market. This study aimed to compare effectiveness of two commercially available 0.2% chlorhexidine mouthwashes. Patients, that after initial periodontal therapy, had a need for two periodontal surgeries, will be invited to join. After one surgical session, the patient will receive one 0.2% chlorhexidine solution, and after the next surgical session the patient will receive the other 0.2% chlorhexidine solution. Plaque and gingivitis will be recorded, as well as side effects.

Interventions

DRUGChlorhexidine 0.2%, Corsodyl

Comparison of Corsodyl and Curasept

DRUGChlorhexidine 0.2%, Curasept

Chlorhexidine 0.2% mouthwash with an Anti Discoloring System (ADS)

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Intra individual cross-over, double intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Periodontitis, stage III and IV

Exclusion criteria

Uncontrolled diabetes Systemic conditions associated with excessive bleeding Uncontrolled hypertension

Design outcomes

Primary

MeasureTime frameDescription
Plaque index14 days intervention periodDental Plaque
Gingival Index14 days intervention periodGingivitis

Countries

Norway

Contacts

Primary ContactErik Mauland, DDS
erik.mauland@hotmail.com004747636914
Backup ContactHans Preus, Professor
h.r.preus@odont.uio.no

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026